
Innovative strategies and good partnerships are means by which developers can overcome the unique challenges in biologics formulation.
Innovative strategies and good partnerships are means by which developers can overcome the unique challenges in biologics formulation.
The new centralized hub will provide advanced testing of nucleic acids, which is expected to simplify mRNA substance testing.
The winners of the 2023 CPHI Pharma Awards were announced on October 25 at the CPHI Barcelona event.
Waters has launched OligoWorks SPE Workflow and Kits, which is aimed at accelerating the bioanalysis of oligonucleotides.
SCHOTT now offers ViewCell, a new component meant to add flexibility to biopharmaceutical process control.
Under an expanded agreement, Cellares will provide proof-of-concept manufacturing for a second CAR-T cell therapy from Bristol Myers Squibb.
Salipro Biotech and Icosagen have entered into a multi-target collaboration to discover and characterize monoclonal antibodies.
Under this agreement, Acuitas Therapeutics’ LNP technology platform will be transferred to BIOVECTRA for use in manufacturing mRNA-based therapies.
The Start-Up Market at CPHI Barcelona brings together 27 start-ups, innovators, and small enterprises from across the pharma landscape.